Home › Research › Getting a diagnosis
Undiagnosed dementia and mortality among older adults in the United States and Brazil: A cross-national cohort study
Aliberti MJR, Avelino-Silva TJ, Covinsky KE, Lam K, Lee SJ, Bertola L, Ferri CP, Lima-Costa MF, Mambrini JVM, Miguel ACC, et al.. Alzheimer's & Dementia, 2026-04-29
Topic: Risk, prevention and care in population studies
Plain-language summary
Introduction Cross-national evidence on undiagnosed dementia and its prognostic implications remains limited. We compared the proportion of undiagnosed dementia, associated factors, and mortality in the United States and Brazil. Methods This population-based cohort study included adults aged ≥ 65 years from the 2016 US Health and Retirement Study (n = 9,539) and the 2015-2016 Brazilian Longitudinal Study of Aging (n = 3603), followed for mortality through 2020. Dementia was classified as no dementia, undiagnosed dementia, or diagnosed dementia using harmonized cognitive, functional, and informant measures. Results The proportion of undiagnosed dementia was higher in Brazil (76.1%) than in the United States (45.1%). Undiagnosed dementia was associated with increased 4-year mortality compared with no dementia in both countries. It was linked to younger age and absence of memory complaints, with marked socioeconomic and healthcare disparities in Brazil. Discussion Undiagnosed dementia is common and associated with increased mortality, identifying a vulnerable population missed by current diagnostic pathways.
What this study adds
Evidence grade: Moderate
This is a follow-up (cohort) study of 13,142 participants. This study found that 76.1% of dementia cases in Brazil and 45.1% in the United States were undiagnosed. Reported effect size: 45.1% (US) and 76.1% (Brazil) of dementia cases undiagnosed.
Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.
Cite this study APA, Vancouver, BibTeX · download .bib or .ris
APA 7th
Aliberti, M. J. R., Avelino-Silva, T. J., Covinsky, K. E., Lam, K., Lee, S. J., Bertola, L., et al. (2026). Undiagnosed dementia and mortality among older adults in the United States and Brazil: A cross-national cohort study. Alzheimer's & Dementia. https://doi.org/10.1002/alz.71430
Vancouver
Aliberti MJR, Avelino-Silva TJ, Covinsky KE, Lam K, Lee SJ, Bertola L, et al. Undiagnosed dementia and mortality among older adults in the United States and Brazil: A cross-national cohort study. Alzheimer's & Dementia. 2026. doi:10.1002/alz.71430. PMID: 42056069.
BibTeX
@article{aliberti2026-42056069,
author = {Aliberti, M. J. R. and Avelino-Silva, T. J. and Covinsky, K. E. and Lam, K. and Lee, S. J. and Bertola, L. and Ferri, C. P. and Lima-Costa, M. F. and Mambrini, J. V. M. and Miguel, A. C. C. and others},
title = {{Undiagnosed dementia and mortality among older adults in the United States and Brazil: A cross-national cohort study}},
journal = {Alzheimer's \& Dementia},
year = {2026},
doi = {10.1002/alz.71430},
pmid = {42056069},
url = {https://doi.org/10.1002/alz.71430}
}
Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record's author list ends in “et al.”, so not every author is named. Check the citation against the original before you use it.
Key findings
- Results The proportion of undiagnosed dementia was higher in Brazil (76.1%) than in the United States (45.1%).
- Undiagnosed dementia was associated with increased 4-year mortality compared with no dementia in both countries.
- Discussion Undiagnosed dementia is common and associated with increased mortality, identifying a vulnerable population missed by current diagnostic pathways.
Why it matters
This study found that 76.1% of dementia cases in Brazil and 45.1% in the United States were undiagnosed. People with undiagnosed dementia had higher 4-year mortality than those without dementia in both countries, which the authors say identifies a vulnerable group missed by current diagnostic pathways.
New to this subject? Start with our plain-English guide: Getting a diagnosis →
Study details
- Study designcohort
- Participants13,142
- Effect size45.1% (US) and 76.1% (Brazil) of dementia cases undiagnosed
- Evidence strengthModerate
Limitations
Dementia classified by survey-based cognitive, functional and informant measures rather than clinical assessment; self-reported diagnosis status; mortality hazard ratios not given in the abstract.
How this study scored 54/100
Published in a leading specialty journal, and it is a cohort study following people over time. Scored zero for randomized / blinded because the record does not state it. We have no data on free to read, so that was left out: it earned 53 of the 98 points we could judge it on, which is 54 out of 100.
| Component | Points | Why |
|---|---|---|
| Journal tier | 9 / 10 | Tier 2 — leading specialty journal (Alzheimer's & Dementia) |
| Journal's citation record | 2 / 4 | Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29) |
| Study design | 7 / 12 | A cohort study following people over time |
| Strength of evidence | 3 / 5 | Rated “moderate” in our summary |
| Peer-review validation | 10 / 10 | Peer-reviewed. Published as an article in a named peer-reviewed journal. |
| How recent | 5 / 5 | 2026 — within 1 year(s) of the newest study here |
| Sample size | 4 / 4 | 13,142 participants |
| Effect reported | 2 / 3 | Effect reported as a number, without an interval or test |
| Studied in people | 3 / 3 | Studied in people (participant count stated) |
| Randomized / blinded | 0 / 2 | No randomization or blinding stated — scores zero (not stated in the record — scored 0) |
| Times cited | 0 / 7 | Cited 0 times (OpenAlex, 2026-10-10) |
| Citations per year | 0 / 5 | 0.0 citations a year over 2 year(s) since 2026 |
| Impact for its field and year | 0 / 6 | Cited 0.0× the average for papers of its field and year (OpenAlex FWCI) |
| Cited by studies here | 0 / 6 | No other study in this library cites it |
| Still being cited | 0 / 4 | Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex) |
| Senior author's track record | 2 / 4 | Last-listed author Cláudia Kimie Suemoto: h-index 48 (OpenAlex, whole career) |
| Institution's track record | 2 / 3 | Johns Hopkins University: institution h-index 2,306 (OpenAlex) |
| Multicenter collaboration | 2 / 3 | OpenAlex lists 9 institution(s) in 2 countries |
| Indexed in PubMed | 2 / 2 | Indexed in PubMed (PMID 42056069) |
| Free to read | — / 2 | Access not recorded — left out of this score |
| Points | 53 / 98 | Scored on 19 of 20 parts. We have no data for the rest, so they are left out: 53 of the 98 points we could judge it on is 54 out of 100. |
| Total | 54 / 100 | — |
What each of these 20 components measures, and what this score is not →
Read the original
Full text: free to read — PubMed Central lists this copy as free to read: the link above (checked 10 Oct 2026).
Related
Studies in the library that share something with this one. The line above each title says what.
Related studies in Getting a diagnosis from nearby years
Also tagged “prevalence”
1,224 studies in the library carry the topic tag “prevalence”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,224 tagged studies.